Orange Book product · Generic (ANDA)
REMIFENTANIL HYDROCHLORIDE
REMIFENTANIL HYDROCHLORIDE
Generic (ANDA)ANDA 215635TE APRX NIVAGEN PHARMS INC
At a glance
Jun 28, 2024
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 28, 2024
2 yr ago
Today
Pharmaceutical detail
Active ingredient
REMIFENTANIL HYDROCHLORIDE
Strength
EQ 1MG BASE/VIAL
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 215635
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of REMIFENTANIL HYDROCHLORIDE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
